📰 Optum Research Database News
Optum Research Database News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optum Research Database. Real-time updates on events, politics, business and more.
February 9, 2024
This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.
December 6, 2023
Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.
October 12, 2023
Patient comorbidities should be considered when prescribing antiretroviral therapy (ART) to treat HIV to avoid comedication drug toxicities.
June 9, 2023
"The take-home finding is that herpes zoster incidence is high among people with MS overall."
May 26, 2023
Investigators probed use of standard-of-care first-line metastatic castration-sensitive prostate cancer (mCSPC) treatment intensification.
May 25, 2023
Investigators probed use of standard-of-care first-line metastatic castration-sensitive prostate cancer (mCSPC) treatment intensification.
January 5, 2023
First-line pembrolizumab-axitinib leads to lower health care resource utilization than ipilimumab-nivolumab in metastatic renal cell carcinoma.
November 21, 2022
The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.
November 18, 2022
Mepolizumab use reduced exacerbations and the use of oral corticosteroids in patients with both allergic and non-allergic asthma.
November 5, 2022
First-line pembrolizumab-axitinib leads to lower health care resource utilization than ipilimumab-nivolumab in metastatic renal cell carcinoma.